Framework helps clinicians identify serious spinal pathology

May 27, 2020

Rehabilitation clinicians and other health care professionals now have a framework for assessing and managing people who may have serious spinal pathologies. Detailed in a position statement about red flags for serious spinal injuries and disease, this new guidance for clinical practice was developed for the International Federation of Orthopaedic Manipulative Physical Therapists (IFOMPT) and Journal of Orthopaedic & Sports Physical Therapy® (JOSPT®).

"While rare, serious spinal pathology can have devastating and life-changing consequences, and must be identified early and managed appropriately," says Laura M. Finucane, MSc, BSc, FCSP, FMACP, lead author of the statement and vice president of IFOMPT. "This framework is intended to provide clinicians with a clinical-reasoning pathway to clarify the role of red flags in recognizing spinal injuries and disease."

IFOMPT drew on the expertise of 100 experts from 19 countries to synthesize current research and reach consensus on the framework. Seventy clinicians from 13 countries, supported by patient partners, reviewed the information and approved the final version of the framework and its decision tools.

The framework covers four serious spine pathologies: cauda equina syndrome, compression of the nerve roots at the base of the spinal cord; spinal fracture, which accounts for the largest number of serious pathologies of the spine; spinal malignancy, which includes cancers that have spread from a primary cancer site to bone; and spinal infection, which includes infectious disease affecting spinal structures. For each pathology, decision tools summarize the red flags; outline the risk factors, symptoms, signs, and initial investigations; and offer a series of scenarios illustrating how red flags may raise suspicion of that condition.

The framework identifies the level of concern clinicians should have and the clinical action they should take, based on available pathways for therapy or referral to specialist care.

"While they often lack high-quality empirical evidence, red flags remain the best tools available to the clinician to raise suspicion of serious spinal pathology when used in the context of a thorough, subjective patient history and physical examination," Finucane says. As a result, the framework's authors urge clinicians to consider both the evidence to support red flags and the individual profile of their patient to decide how concerned they are that a serious condition exists.
-end-
The position statement is titled "International Framework for Red Flags for Potential Serious Spinal Pathologies." Co-authors on the paper are Aron Downie, MPhil, BSc, MChiro, of Macquarie University and The University of Sydney in North Ryde and Sydney, Australia, respectively; Christopher Mercer, MSc, Grad Dip Phys, PG Cert (Clin Ed), FCSP, FMACP, of Western Sussex Hospitals NHS Foundation Trust, Chichester, United Kingdom; Susan M. Greenhalgh, PhD, MA, Phys FCSP, of Bolton NHS Foundation Trust and Manchester Metropolitan University in Bolton and Manchester, United Kingdom, respectively; William G. Boissonnault, PT, DPT, DHSc, of the American Physical Therapy Association, Alexandria, Virginia, United States; Annelies L. Pool-Goudzwaard, PT, PhD, MT, MSc Psych, of Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Jason M. Beneciuk, PT, DPT, PhD, MPH, of the University of Florida and Brooks Rehabilitation in Gainesville and Jacksonville, Florida, United States, respectively; Rachel L. Leech, MSc, BSc, of Manchester Metropolitan University, Manchester, United Kingdom; and James Selfe, DSc, PhD, MA, Grad Dip Phys, FCSP, Manchester Metropolitan University, Manchester, United Kingdom, and Satakunta University of Applied Sciences, Pori, Finland.

The position statement's full citation is: J Orthop Sports Phys Ther 2020;50(7). Epub 21 May 2020. doi:10.2519/jospt.2020.9971. The statement is available at:
https://www.jospt.org/doi/10.2519/jospt.2020.9971. The framework will be published in print in JOSPT's July 2020 issue.

The following organizations provided financial support for the development and dissemination of this framework: the Canadian Academy of Manipulative Physiotherapy, Chartered Society of Physiotherapy, International Maitland Teachers Association, Musculoskeletal Association of Chartered Physiotherapists, Private Physiotherapy Educational Foundation, and Swiss Association for Orthopaedic Manipulative Physiotherapy.

For more information, please contact Ms. Finucane at laura.finucane@nhs.net, or JOSPT Editor-in-Chief Clare L. Ardern, PT, PhD, at clare.ardern@ki.se.

About the Journal of Orthopaedic & Sports Physical Therapy

The Journal of Orthopaedic & Sports Physical Therapy® (JOSPT®) publishes scientifically rigorous, clinically relevant content for rehabilitation clinicians, including physical therapists, and others in the health care community to advance musculoskeletal and sports-related practice globally. JOSPT is an independent, non-profit journal, published by JOSPT, Inc. d/b/a Movement Science Media. For more information, visit http://www.jospt.org.

JOSPT, Inc. d/b/a Movement Science Media

Related Disease Articles from Brightsurf:

CLCN6 identified as disease gene for a severe form of lysosomal neurodegenerative disease
A mutation in the CLCN6 gene is associated with a novel, particularly severe neurodegenerative disorder.

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

Potential link for Alzheimer's disease and common brain disease that mimics its symptoms
A new study by investigators from Brigham and Women's Hospital uncovered a group of closely related genes that may capture molecular links between Alzheimer's disease and Limbic-predominant Age-related TDP-43 Encephalopathy, or LATE, a recently recognized common brain disorder that can mimic Alzheimer's symptoms.

Antioxidant agent may prevent chronic kidney disease and Parkinson's disease
Researchers from Osaka University developed a novel dietary silicon-based antioxidant agent with renoprotective and neuroprotective effects.

Tools used to study human disease reveal coral disease risk factors
In a study published in Scientific Reports, a team of international researchers led by University of Hawai'i (UH) at Mānoa postdoctoral fellow Jamie Caldwell used a statistical technique typically employed in human epidemiology to determine the ecological risk factors affecting the prevalence of two coral diseases--growth anomalies, abnormalities like coral tumors, and white syndromes, infectious diseases similar to flesh eating bacteria.

Disease-aggravating mutation found in a mouse model of neonatal mitochondrial disease
The new mitochondrial DNA (mtDNA) variant drastically speeds up the disease progression in a mouse model of GRACILE syndrome.

Human longevity largest study of its kind shows early detection of disease & disease risks
Human Longevity, Inc. (HLI) announced the publication of a ground-breaking study in the journal Proceedings of the National Academy of Sciences (PNAS).

30-year study identifies need of disease-modifying therapies for maple syrup urine disease
A new study analyzes 30 years of patient data and details the clinical course of 184 individuals with genetically diverse forms of Maple Syrup Urine Disease (MSUD), which is among the most volatile and dangerous inherited metabolic disorders.

Long-dormant disease becomes most dominant foliar disease in New York onion crops
Until recently, Stemphylium leaf blight has been considered a minor foliar disease as it has not done much damage in New York since the early 1990s.

Read More: Disease News and Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.